The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...

There is in fact a greater than 3-fold risk with affected first-degrees family members,” Dr. Dawn Eichefield said.

BoXer releases this 'payload' locally at the site of bone lesions, offering a dual therapeutic benefit—bone regeneration and localized myeloma control," adds Dr. Anja Seckinger of TORC.

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

A new study links drinking green tea with having fewer white matter lesions in the brains of Japanese seniors, potentially providing a level of protection against dementia. Researchers from ...

Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of ...

Multiple sclerosis (MS) is a chronic condition affecting the central nervous system. Its symptoms range from mild and intermittent to severe and permanently damaging. There’s currently no cure ...

Wilms tumor (also called nephroblastoma) is the most common type of kidney cancer in children. About 9 of 10 kidney cancers in children are Wilms tumors. These cancers are different from adult kidney ...

CGL subtypes 1 and 2 present sclerosis and osteolytic lesions that can resemble “pagetic” lesions. The clinical correlation is, therefore, essential. We report a CGL patient with bone lesions in which ...